The quarter reflected steady revenue growth but underscored challenges in profit conversion, as seen in declining operating ...

G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company ...

The medical device company has seen its growth rate take a hit in recent quarters. DexCom blames its restructuring, but rising demand for GLP-1 drugs could be an issue. The stock's valuation has ...

Upgrading to Limited Access to the Dexcom ... G6 and G7 Continuous Glucose Monitors. Achieving these goals will result in a fully functional mobile app capable of integrating with CGM data-an ...

Persuade people with Type 1 diabetes to learn about the Dexcom G6 Continuous Glucose Monitor – overcoming low category/brand awareness. If people with T1D could choose any superpower, they'd choose ...

DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...

SAN DIEGO, January 15, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2024 results ...

In March 2024, the Food and Drug Administration cleared Dexcom’s Stelo as the ... Yet, despite the conceptual benefits of using continuous glucose monitoring for optimizing exercise, there ...